Research programme: WEE1 targeting therapeutics - DeepCure
Latest Information Update: 31 Mar 2023
At a glance
- Originator DeepCure
- Class Small molecules
- Mechanism of Action WEE1 protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Unspecified
Most Recent Events
- 22 Mar 2023 Early research in Unspecified in USA (PO) (DeepCure pipeline, March 2023)